<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Synthetic Data 101 for Healthcare: Fraud Detection Without PHI/PII | Auspexi</title>
  <style>
    body {
      font-family: 'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
      line-height: 1.6;
      color: #2d3748;
      max-width: none;
      margin: 0 auto;
      padding: 2rem;
      background-color: #f7fafc;
    }
    h1 {
      font-size: 2.5rem;
      color: #1a202c;
      margin-bottom: 1rem;
      line-height: 1.2;
    }
    h2 {
      font-size: 1.8rem;
      color: #2b6cb0;
      margin-top: 2rem;
      margin-bottom: 1rem;
    }
    h3 {
      font-size: 1.5rem;
      color: #2b6cb0;
      margin-top: 1.5rem;
      margin-bottom: 0.75rem;
    }
    p {
      margin-bottom: 1.5rem;
      font-size: 1.1rem;
    }
    em {
      font-style: italic;
      color: #4a5568;
    }
    ul, ol {
      margin-bottom: 1.5rem;
      padding-left: 2rem;
    }
    li {
      margin-bottom: 0.5rem;
      font-size: 1.1rem;
    }
    pre {
      background-color: #f8f9fa;
      color: #2d3748;
      border: 1px solid #e2e8f0;
      padding: 1rem;
      border-radius: 0.5rem;
      overflow-x: auto;
      font-size: 0.95rem;
      margin-bottom: 1.5rem;
    }
    code {
      font-family: 'Fira Code', monospace;
    }
    table {
      width: 100%;
      border-collapse: collapse;
      margin-bottom: 1.5rem;
      background-color: #fff;
      box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    th, td {
      padding: 0.75rem;
      border: 1px solid #e2e8f0;
      text-align: left;
      font-size: 1rem;
    }
    th {
      background-color: #2b6cb0;
      color: #fff;
    }
    details {
      margin-bottom: 1rem;
      background-color: #edf2f7;
      padding: 1rem;
      border-radius: 0.5rem;
    }
    summary {
      font-weight: bold;
      cursor: pointer;
      color: #2b6cb0;
      font-size: 1.1rem;
    }
    .aeg-btn {
      display: inline-block;
      background-color: #2b6cb0;
      color: #fff;
      padding: 0.75rem 1.5rem;
      border-radius: 0.5rem;
      text-decoration: none;
      font-weight: bold;
      transition: background-color 0.3s;
      margin-top: 1rem;
    }
    .aeg-btn:hover {
      background-color: #2c5282;
    }
    img {
      width: 100%;
      height: auto;
      max-width: 100vw;
      margin: 0 -2rem;
      display: block;
    }
    blockquote {
      border-left: 4px solid #2b6cb0;
      padding-left: 1rem;
      margin: 1.5rem 0;
      color: #2d3748;
      font-style: italic;
    }
    .kv-list {
      margin: 1rem 0 1.5rem 0;
      display: grid;
      grid-template-columns: 1fr;
      gap: 0.5rem;
    }
    .kv {
      display: flex;
      align-items: flex-start;
      gap: 0.5rem;
      background: #ffffff;
      border: 1px solid #e2e8f0;
      border-radius: 0.5rem;
      padding: 0.6rem 0.8rem;
    }
    .kv .key {
      min-width: 180px;
      font-weight: 600;
      color: #1e40af;
      white-space: nowrap;
    }
    .kv .value {
      color: #4a5568;
    }
    @media (max-width: 600px) {
      body {
        padding: 1rem;
      }
      h1 {
        font-size: 2rem;
      }
      h2 {
        font-size: 1.5rem;
      }
      h3 {
        font-size: 1.3rem;
      }
      p, li {
        font-size: 1rem;
      }
      img {
        margin: 0 -1rem;
      }
    }
    pre, code, pre *, code * { color: #1f2937 !important; background: #f8fafc !important; }
    [style*="color:#000"], [style*="color: #000"], [style*="color:black"], [style*="color: black"], [style*="color:rgb(0,0,0)"] { color: #1f2937 !important; }
    [style*="background:#000"], [style*="background: #000"], [style*="background-color:#000"], [style*="background-color: #000"], [style*="background:rgb(0,0,0)"], [style*="background-color:rgb(0,0,0)"] { background-color: #f8fafc !important; }
  </style>
</head>
<body>
  <h1>Synthetic Data 101 for Healthcare: Fraud Detection Without PHI/PII</h1>
  <p><em>By Gwylym Owen — 20–28 min read</em></p>

  <h2>Executive Summary</h2>
  <p>Hey, healthcare fraud programs hit a wall when privacy rules block sharing, testing, and verification—frustrating, right? AethergenPlatform rolls out a synthetic-first pipeline that nails <strong>behavior</strong> without spilling <strong>identity</strong>, mate! Teams can prototype, evaluate, and prove fraud detectors with corpora that mirror real claims—PHI/PII-free. This piece walks you through the data model, generation tricks, typology library, eval gates, and evidence packaging to go from pilot to production in regulated zones, as of September 2025!</p>

  <h2>Problem Context</h2>
  <p>Fraud typologies outpace change-control, and it’s a mess! Rules stale out, models drift, and analysts drown. Real data can’t leave secure zones, so collaboration stalls, tools stay untested, and vendor claims are tough to trust. Synthetic corpora bring <strong>safe iteration</strong>, <strong>repeatable evaluation</strong>, and <strong>solid procurement evidence</strong>—let’s fix that!</p>

  <h2>Clinical-Claims Data Model</h2>
  <p>Here’s the blueprint, simplified:</p>
  <ul>
    <li><strong>Entities</strong>: Patient (de-identified), provider, facility, payer plan, claim, line item, prescription, lab event—keep it real!</li>
    <li><strong>Core Attributes</strong>: Dates, CPT/HCPCS/ICD codes, NPI/specialty (synthetic), amounts (billed/allowed/paid), place of service, modifiers, units, referrals, prior auth flags—cover the bases!</li>
    <li><strong>Relations</strong>: Provider↔facility affiliation, patient↔provider panels, claim↔line items, episodes of care, referral chains, pharmacy fill sequences—tie it together!</li>
  </ul>

  <h2>Dataset Schema Example</h2>
  <pre>
claims(
  claim_id, patient_id*, provider_id*, facility_id*, date, pos,
  cpt, icd10, modifiers, units, amount_billed, amount_allowed, amount_paid,
  payer_plan, referral_flag, prior_auth_flag
)

lines(
  line_id, claim_id, cpt, icd10, modifiers, units, npi*, specialty,
  amount_billed, amount_allowed, amount_paid
)

rx(
  rx_id, patient_id*, provider_id*, date, drug_class, dose, days_supply,
  payment_amount, device_id*
)

labs(
  lab_id, patient_id*, loinc_code, result_band, units, date
)

*Synthetic identifiers only; no PHI/PII in evaluation corpora.
  </pre>

  <h2>Metrics Appendix</h2>
  <p>Measure what matters:</p>
  <ul>
    <li><strong>Lift@Budget</strong>: Cases found at fixed FPR (0.5%, 1%, 2%)—hit the target!</li>
    <li><strong>Stability</strong>: Max segment delta across specialty/region/plan bands—keep it steady!</li>
    <li><strong>Drift Early-Warning</strong>: Change-point scores for code usage and cadence—spot the shifts!</li>
    <li><strong>Analyst Yield</strong>: Cases per analyst-hour at chosen thresholds—maximize efficiency!</li>
    <li><strong>Privacy</strong>: Membership/attribute probe advantage vs random—lock it down!</li>
  </ul>

  <h2>Acceptance Checklist</h2>
  <p>Your go-to list:</p>
  <ul>
    <li><strong>Target KPI</strong>: Defined and tied to analyst staffing—set the goal!</li>
    <li><strong>Operating Points</strong>: Fixed with CI bands reported—clear metrics!</li>
    <li><strong>Privacy Probes</strong>: Under thresholds (DP budgets if used)—secure it!</li>
    <li><strong>Drift Monitors</strong>: Documented rollback rules—plan for change!</li>
    <li><strong>Evidence Bundle</strong>: Signed and archived—proof ready!</li>
  </ul>

  <h2>Case Study</h2>
  <p><strong>Scenario</strong>: A simulated regional upcoding sweep for a payer.</p>
  <p>A four-week pilot on orthopedic claims locked operating points at 1% FPR. The synthetic-trained baseline boosted reviewed-case yield by 23% versus legacy rules and cut false escalations by 11%. Stability held across three regions; privacy probes showed no risk spikes. Procurement accepted with gates and rollback defined—mission accomplished!</p>

  <h2>FAQ</h2>
  <details>
    <summary>Does synthetic data replace real investigations?</summary>
    <p>Nope—synthetic data swaps unsafe sharing and vendor demos for safe, repeatable eval. Real investigations stay the gold standard for adjudication; synthetic preps the system to shine before live data!</p>
  </details>
  <details>
    <summary>Can we tune prevalence to stress analysts?</summary>
    <p>You bet! Typologies are adjustable—simulate surges or rare outliers to test workload and triage policy, mate!</p>
  </details>
  <details>
    <summary>How do you prevent overfitting to synthetic quirks?</summary>
    <p>We use ablation to ensure robust features win; sanity-check rankings on approved internal samples; and lay out limits in the evidence bundle—keeping it real!</p>
  </details>

  <h2>Glossary</h2>
  <ul>
    <li><strong>Operating Point</strong>: Threshold where the detector runs in production—your line in the sand!</li>
    <li><strong>Evidence Bundle</strong>: Signed package of metrics, configs, seeds, and hashes—your proof pack!</li>
    <li><strong>Membership Inference</strong>: Attack checking if a record influenced training—test the leaks!</li>
    <li><strong>DP</strong>: Differential privacy; limits any one record’s impact—privacy power!</li>
  </ul>

  <h2>Procurement Q&A</h2>
  <ul>
    <li><strong>Export Formats</strong>: Parquet/Delta; dashboards as HTML/PDF; notebooks as HTML—flexible delivery!</li>
    <li><strong>Runtime</strong>: On-prem preferred; VPC supported; no PHI/PII leaves the enclave—secure as can be!</li>
    <li><strong>Support</strong>: SLAs for evidence regen and drift incident triage—got your back!</li>
  </ul>

  <h2>Contact</h2>
  <p>Ready to tackle fraud detection safely and smartly? <a href="/contact">Chat with us</a> about a focused pilot, mate!</p>

  <h2>Generation Pipeline</h2>
  <p>Let’s build it step by step:</p>
  <ol>
    <li><strong>Schema Design</strong>: Pick fields and ranges for fraud utility; encode CPT families, ICD hierarchies—set the stage!</li>
    <li><strong>Distribution Learning</strong>: Learn marginals and joint structure from seeds/redacted aggregates; fit copulas or conditionals—keep dependencies alive!</li>
    <li><strong>Sequence Synthesis</strong>: Craft episode timelines (admissions→procedures→discharge; refills) with realistic timing and seasonality—tell the story!</li>
    <li><strong>Typology Injection</strong>: Add parameterised fraud behaviors (below) with tunable prevalence and severity—mix it up!</li>
    <li><strong>Validation</strong>: Run fidelity and privacy checks; tweak until thresholds pass—make it solid!</li>
  </ol>

  <h2>Fidelity: What “Good Enough” Means</h2>
  <p>Here’s the standard:</p>
  <ul>
    <li><strong>Marginals</strong>: Code, specialty, geography, amount distributions within tolerances—align it!</li>
    <li><strong>Joints</strong>: Realistic provider-procedure-amount ties; plausible co-coding; age-procedure fits—make sense!</li>
    <li><strong>Temporal</strong>: Weekday/season effects; episode lengths; refill cadences; denial/rebill loops—capture the flow!</li>
    <li><strong>Tail Coverage</strong>: Keep rare but plausible events; cap impossibles with constraints—cover the edges!</li>
    <li><strong>Utility Checks</strong>: Baseline detectors on synthetic hit target lift on hold-out synthetic and match rankings on approved samples—prove it works!</li>
  </ul>

  <h2>Privacy: What We Measure</h2>
  <p>No assumptions here:</p>
  <ul>
    <li><strong>Process Isolation</strong>: Eval corpora have no PHI/PII; seeds are minimal and controlled—locked tight!</li>
    <li><strong>Membership Inference</strong>: Attacks show low advantage at release settings—test it!</li>
    <li><strong>Attribute Disclosure</strong>: Sensitive prediction stays at/below baseline leakage—safe bets!</li>
    <li><strong>Differential Privacy (Optional)</strong>: Per-policy ε, δ budgets with impact notes when mandated—privacy with power!</li>
  </ul>

  <h2>Fraud Typology Library</h2>
  <p>Tune these fraud flavors:</p>
  <ul>
    <li><strong>Upcoding</strong>: Inflate CPT within specialties; adjust overbilling factor, code families, audit risk—catch the cheats!</li>
    <li><strong>Unbundling</strong>: Split components; tweak compliance pressure and recurrence—spot the splits!</li>
    <li><strong>Phantom Billing</strong>: Claims sans service; vary facility mix, distance anomalies, timing clashes—phantom busters!</li>
    <li><strong>Doctor Shopping</strong>: Overlapping scripts; control window, drug class, device ties—track the hoppers!</li>
    <li><strong>Duplicate Billing</strong>: Repeat claims with modifiers; adjust delay and payer rules—double trouble!</li>
    <li><strong>Kickback Rings</strong>: Referral cycles with odd financials; expose graph motifs and flows—ring the alarm!</li>
  </ul>

  <h2>Feature Families</h2>
  <p>Build the signals:</p>
  <ul>
    <li><strong>Code Semantics</strong>: Family distance, incompatible pairs, specialty fits—code savvy!</li>
    <li><strong>Temporal</strong>: Visit cadence, inter-arrival z-scores, day/week effects—time it right!</li>
    <li><strong>Financial</strong>: Amount residuals vs peers, payer mix quirks, denial/rebill patterns—money talks!</li>
    <li><strong>Graph</strong>: Provider-patient motifs, referral cycles, shared devices—connect the dots!</li>
  </ul>

  <h2>Modeling and Thresholds</h2>
  <p>Keep it clear and strong:</p>
  <p>Use transparent baselines (rules, tree ensembles) with deep models for lift and interpretability. Pick <strong>operating points</strong> matching investigator capacity (alerts/day/team) and share the trade-off. Pilots often target “+X% cases at fixed FPR” over raw AUC—practical wins!</p>

  <h2>Evaluation Gates</h2>
  <p>Procurement-ready checks:</p>
  <ul>
    <li><strong>Operating Point Utility</strong>: Detection at fixed FPR budgets with CIs—hit the mark!</li>
    <li><strong>Segment Stability</strong>: Specialty, region, plan type deltas within bounds—steady as she goes!</li>
    <li><strong>Drift Sensitivity</strong>: Early-warning KPIs under simulated shifts—stay alert!</li>
    <li><strong>Analyst Cost Curves</strong>: Incremental cases per analyst-hour—maximize effort!</li>
    <li><strong>Privacy Gates</strong>: Probes under thresholds; DP budgets honored if used—secure it!</li>
  </ul>

  <h2>Evidence Bundle</h2>
  <p>Shipped with every release:</p>
  <ul>
    <li><strong>Hashes</strong>: Schema, recipe, environment; SBOM for artifacts—full trace!</li>
    <li><strong>Fidelity Metrics</strong>: CIs, visual comparisons for marginals/joints—see the fit!</li>
    <li><strong>Privacy Results</strong>: Probes and interpretations; DP params if used—lock it down!</li>
    <li><strong>Ablation Table</strong>: Feature/recipe impacts—keep the winners!</li>
    <li><strong>Notes</strong>: Use, limits, drift monitors, rollback rules, change-control—cover all bases!</li>
  </ul>

  <h2>Pilot → Policy in Four Weeks</h2>
  <p>Your roadmap:</p>
  <ol>
    <li><strong>Week 1</strong>: Pick a typology and KPI; lock schema; generate v1 corpora—kick it off!</li>
    <li><strong>Week 2</strong>: Train baselines; tune operating points; check fidelity/privacy—refine it!</li>
    <li><strong>Week 3</strong>: Red-team failures; set gates; package evidence—test the edges!</li>
    <li><strong>Week 4</strong>: Run acceptance with stakeholders; sign off thresholds and rollback—seal the deal!</li>
  </ol>

  <h2>Integration</h2>
  <p>Plug it in:</p>
  <ul>
    <li><strong>Deployment</strong>: On-prem or private cloud; edge bundles for air-gapped review—flexible fit!</li>
    <li><strong>Data Interchange</strong>: Parquet/Delta; Databricks-ready jobs—smooth flow!</li>
    <li><strong>Governance</strong>: Signed evidence bundles in CI/CD and doc control—locked tight!</li>
  </ul>

  <blockquote>
    <p><strong>AethergenPlatform</strong> proves claims with <em>evidence</em>. You get realism sans identifiers, clear utility at your alert budget, and reproducible packages that satisfy audit—nice work, mate!</p>
  </blockquote>

  <p><a href="/contact" class="aeg-btn">Contact Sales →</a></p>

  <h2>Worked Example: Upcoding Review</h2>
  <p>Let’s break it down:</p>
  <ol>
    <li><strong>Setup</strong>: Define CPT family and specialty constraints; set cost bands—lay the ground!</li>
    <li><strong>Generate</strong>: Create cohort with tunable upcoding prevalence and factor—mix it up!</li>
    <li><strong>Train</strong>: Baseline trees + rules; calibrate to 1% FPR—tune it tight!</li>
    <li><strong>Report</strong>: Cases per analyst-hour with explanations and feature contributions—show the win!</li>
  </ol>

  <h2>Worked Example: Doctor Shopping</h2>
  <p>Another go:</p>
  <ol>
    <li><strong>Emit</strong>: Overlapping prescription sequences across providers and pharmacies—build the case!</li>
    <li><strong>Construct</strong>: Device/address correlations and cadence features—connect the dots!</li>
    <li><strong>Compare</strong>: Rules vs learned models; tweak escalation policies—find the best!</li>
    <li><strong>Publish</strong>: Stability across regions and plan types—prove it holds!</li>
  </ol>

  <h2>Analyst Experience</h2>
  <p>Make it easy:</p>
  <ul>
    <li><strong>Reproducible Notebooks</strong>: Tied to evidence bundle versions—trace it back!</li>
    <li><strong>Scenario Sliders</strong>: Adjust prevalence/severity without coding—play with it!</li>
    <li><strong>One-Click Reruns</strong>: Fixed seeds for training—quick and consistent!</li>
  </ul>

  <h2>Limits and Non-Goals</h2>
  <p>Know the boundaries:</p>
  <ul>
    <li><strong>No Perfect Match</strong>: Synthetic doesn’t mimic micro-populations perfectly; we measure fidelity and disclose limits—honest approach!</li>
    <li><strong>No PHI/PII</strong>: Eval corpora stay identifier-free—no leaks!</li>
    <li><strong>No Fragile Heuristics</strong>: Features validated via ablation—robust wins!</li>
  </ul>

  <h2>Next Steps</h2>
  <p>Let’s get moving:</p>
  <ul>
    <li><strong>Pick Typology</strong>: Choose one and a KPI; plan a two-week pilot—start small!</li>
    <li><strong>Align Gates</strong>: Match acceptance with investigator capacity—set the bar!</li>
    <li><strong>Review Evidence</strong>: Check the draft bundle before promotion—finalize it!</li>
  </ul>
</body>
</html>